454 Life Sciences Receives $5 million NIH Grant for Ultraminiaturized Technology to Sequence Whole Human Genomes
Award recognizes the potential of 454 Life Sciences' technology to routinely sequence individual human genomes
15-Oct-2004 -
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), announced today that the Company was awarded a $5 million grant over three years from the National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH) to develop the Company's ...
bacteria
DNA sequencing
genome sequencing
+5